DE69417242D1 - Fluoreszenz-sauerstoffkanalisation-immunteste - Google Patents

Fluoreszenz-sauerstoffkanalisation-immunteste

Info

Publication number
DE69417242D1
DE69417242D1 DE69417242T DE69417242T DE69417242D1 DE 69417242 D1 DE69417242 D1 DE 69417242D1 DE 69417242 T DE69417242 T DE 69417242T DE 69417242 T DE69417242 T DE 69417242T DE 69417242 D1 DE69417242 D1 DE 69417242D1
Authority
DE
Germany
Prior art keywords
oxygen channel
immunity tests
fluorescence oxygen
channel immunity
fluorescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69417242T
Other languages
English (en)
Other versions
DE69417242T2 (de
Inventor
Dariush Davalian
Rajendra Singh
Edwin Ullman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of DE69417242D1 publication Critical patent/DE69417242D1/de
Publication of DE69417242T2 publication Critical patent/DE69417242T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
DE69417242T 1993-09-03 1994-08-29 Fluoreszenz-sauerstoffkanalisation-immunteste Expired - Lifetime DE69417242T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11736593A 1993-09-03 1993-09-03
PCT/US1994/009705 WO1995006877A1 (en) 1993-09-03 1994-08-29 Fluorescent oxygen channeling immunoassays

Publications (2)

Publication Number Publication Date
DE69417242D1 true DE69417242D1 (de) 1999-04-22
DE69417242T2 DE69417242T2 (de) 1999-07-08

Family

ID=22372509

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69417242T Expired - Lifetime DE69417242T2 (de) 1993-09-03 1994-08-29 Fluoreszenz-sauerstoffkanalisation-immunteste

Country Status (8)

Country Link
US (2) US5616719A (de)
EP (1) EP0716746B1 (de)
JP (1) JP3498960B2 (de)
AT (1) ATE177842T1 (de)
CA (1) CA2170873A1 (de)
DE (1) DE69417242T2 (de)
ES (1) ES2135597T3 (de)
WO (1) WO1995006877A1 (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5578498A (en) 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6002000A (en) * 1992-07-20 1999-12-14 Dade Behring Marburg Gmbh Chemiluminescent compounds and methods of use
EP0651752A1 (de) * 1992-07-20 1995-05-10 Behringwerke Ag Chemilumineszierende derivate und methoden deren anwendung
IT1275571B (it) * 1995-07-19 1997-08-07 Consiglio Nazionale Ricerche Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori
US5811253A (en) * 1995-09-01 1998-09-22 Johnson & Johnson Clinical Diagnostics, Inc. Use of vanadium bromoperoxidase as a signal-generating enzyme for chemiluminescent systems: test kits and analytical methods
AU1792697A (en) * 1996-02-19 1997-09-02 Holtz, Alexander Photosensitive composition
EP0852012B1 (de) * 1996-05-01 2006-07-26 Dade Behring Marburg GmbH Chemilumineszente zusammensetungen und ihre verwendung zum nachweis von wasserstoffperoxid
US6432662B1 (en) * 1997-04-15 2002-08-13 Pierce Chemical Company Assay of peroxidase activity
EP0983509B1 (de) 1997-05-14 2005-08-17 Biosite Diagnostics Inc. Schnelle bestimmung des verhältnisses von biologischen molekülen
DE19756773A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Neues Verfahren und Diagnosemittel zur Hämostase-Diagnostik
DE19756782A1 (de) 1997-12-19 1999-06-24 Dade Behring Marburg Gmbh Nachweis und Bestimmung festphasenassoziierter Faktoren
AU2117599A (en) * 1998-01-20 1999-08-02 Mayo Foundation For Medical Education And Research Simplified mutation detection
AU2679899A (en) * 1998-02-18 1999-09-06 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
DE19811017A1 (de) * 1998-03-13 1999-09-16 Dade Behring Marburg Gmbh Neues Verfahren zur Bestimmung von Plasmaproteinen und Faktoren der Hämostase sowie ein neues, implantierbares Meßgerät
DE19846148C2 (de) * 1998-10-01 2002-10-10 Igor Popov Verfahren zur Beurteilung der oxidativen Modifikation proteinhaltiger Stoffe mittels Messung ihrer antiradikalen Aktivität
US7759133B2 (en) * 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
US20040248150A1 (en) * 1999-04-02 2004-12-09 Sharat Singh Methods employing oligonucleotide-binding e-tag probes
US6322980B1 (en) 1999-04-30 2001-11-27 Aclara Biosciences, Inc. Single nucleotide detection using degradation of a fluorescent sequence
US6627400B1 (en) 1999-04-30 2003-09-30 Aclara Biosciences, Inc. Multiplexed measurement of membrane protein populations
US7001725B2 (en) 1999-04-30 2006-02-21 Aclara Biosciences, Inc. Kits employing generalized target-binding e-tag probes
US7037654B2 (en) 1999-04-30 2006-05-02 Aclara Biosciences, Inc. Methods and compositions for enhancing detection in determinations employing cleavable electrophoretic tag reagents
US20030235832A1 (en) * 2000-06-21 2003-12-25 Ahmed Chenna Multiplexed analysis by chromatographic separation of molecular tags
US6649351B2 (en) 1999-04-30 2003-11-18 Aclara Biosciences, Inc. Methods for detecting a plurality of analytes by mass spectrometry
US6673550B2 (en) 1999-04-30 2004-01-06 Aclara Biosciences, Inc. Electrophoretic tag reagents comprising fluorescent compounds
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
EP1110970B1 (de) 1999-12-22 2008-05-14 Dade Behring Marburg GmbH Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung
ES2280170T3 (es) 1999-12-22 2007-09-16 Dade Behring Marburg Gmbh Soluciones de procalcitonina humana.
EP1267935A2 (de) 2000-01-12 2003-01-02 Light Sciences Corporation Behandlung von augenerkrankungen
US7179660B1 (en) 2000-03-06 2007-02-20 Dade Behring Marburg Gmbh Carriers coated with polysaccharides, their preparation and use
US7537938B2 (en) * 2000-04-28 2009-05-26 Monogram Biosciences, Inc. Biomarker detection in circulating cells
US20030207300A1 (en) * 2000-04-28 2003-11-06 Matray Tracy J. Multiplex analytical platform using molecular tags
US7160735B2 (en) * 2000-04-28 2007-01-09 Monogram Biosciences, Inc. Tagged microparticle compositions and methods
US7771929B2 (en) * 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
JP4796259B2 (ja) 2000-05-04 2011-10-19 シーメンス・ヘルスケア・ダイアグノスティックス・プロダクツ・ゲーエムベーハー 複数のアナライトの検出において使用するための組成物
US7635571B2 (en) * 2000-12-07 2009-12-22 Siemens Healthcare Diagnostics Products Gmbh Amplified signal in binding assays
DE10064827A1 (de) 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US7087395B1 (en) 2001-01-16 2006-08-08 Quest Diagnostics Investments Incorporated Vitamin D assay
WO2002078906A2 (en) * 2001-03-29 2002-10-10 Cellect Technologies Corp. Methods devices and systems for sorting and separating particles
PL373962A1 (en) * 2001-05-21 2005-09-19 Aclara Biosciences, Inc. Methods and compositions for analyzing proteins
WO2002094998A2 (en) 2001-05-21 2002-11-28 Aclara Biosciences, Inc. Analyzing phosphorylated proteins
AU2002344221A1 (en) * 2001-05-26 2002-12-09 Aclara Biosciences, Inc. Catalytic amplification of multiplexed assay signals
WO2003005030A1 (en) 2001-07-02 2003-01-16 Arctic Diagnostics Oy Two-photon absorbing dipyrrometheneboron difluoride dyes and their applications
US7045311B2 (en) * 2001-10-25 2006-05-16 Monogram Biosciences, Inc. Whole cell assay systems for cell surface proteases
AU2003222253A1 (en) * 2002-03-05 2003-09-22 Monogram Biosciences, Inc. Multiplex analysis using membrane-bound sensitizers
DE10212960A1 (de) * 2002-03-22 2003-10-23 Gnothis Holding Sa Ecublens Verwendung von Oxazin-Farbstoffen als Markierungsgruppen für die Einzelmolekülanalyse
US7402397B2 (en) * 2002-05-21 2008-07-22 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
US20040229293A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui Surface receptor complexes as biomarkers
US20040229294A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
US20040229380A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB heterodimers as biomarkers
US20040229299A1 (en) * 2002-05-21 2004-11-18 Badal M. Youssouf Intracellular complexes as biomarkers
US20030232394A1 (en) * 2002-06-12 2003-12-18 Aventis Pharma Deutschland Gmbh High throughput screening method and assay system for determining the interaction between C-reactive protein and components binding to it
DE10226011A1 (de) * 2002-06-12 2004-01-08 Aventis Pharma Deutschland Gmbh HTS-fähiges Verfahren und Testsystem zur Ermittlung der Wechselwirkung zwischen c-reaktivem Protein und an C-reaktives Protein bindenden Komponenten
US20030232401A1 (en) * 2002-06-12 2003-12-18 Pugia Michael J. Bacterial test method by glycated label binding
US20040175765A1 (en) * 2002-07-05 2004-09-09 Sharat Singh Cell-screening assay and composition
WO2004011900A2 (en) * 2002-07-25 2004-02-05 Aclara Biosciences, Inc. Detecting receptor oligomerization
WO2004010842A2 (en) * 2002-07-26 2004-02-05 Aclara Biosciences, Inc. Lipophilic electrophoretic probes
US7402398B2 (en) * 2003-07-17 2008-07-22 Monogram Biosciences, Inc. Measuring receptor homodimerization
US7381370B2 (en) 2003-07-18 2008-06-03 Dade Behring Inc. Automated multi-detector analyzer
WO2005019470A2 (en) * 2003-08-11 2005-03-03 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
WO2005085849A2 (en) * 2003-10-24 2005-09-15 U S. Genomics, Inc Biohazard identification by fluorescent immunoassay and single molecule detection
WO2005045058A2 (en) * 2003-10-27 2005-05-19 Monogram Biosciences, Inc. Detecting human anti-therapeutic antibodies
WO2005062048A1 (de) 2003-12-01 2005-07-07 Dade Behring Marburg Gmbh Homogenes nachweisverfahren
DE102005026163A1 (de) 2004-08-24 2006-03-02 Dade Behring Marburg Gmbh Gegen den Marburg I Polymorphismus der Faktor VII aktivierenden Protease (FSAP) gerichtete Antikörper, ihre Herstellung und Verwendung
DE102004042124B4 (de) * 2004-08-30 2006-07-06 Dade Behring Marburg Gmbh Homogenes Verfahren zur Bestimmung eines Analyten in Gegenwart eines Überschusses von kreuzreagierenden Substanzen
US7189582B2 (en) 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
DE102005022047A1 (de) 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US20060281104A1 (en) * 2005-06-13 2006-12-14 Macevicz Stephen C Leuco dye particles and uses thereof
US20080312092A1 (en) * 2005-07-08 2008-12-18 The University Of Denver Photoinduced Signal Amplification Through Externally Sensitized Photofragmentation in Masked Photosensitizers
JP5055289B2 (ja) 2005-11-17 2012-10-24 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド アッセイにおける非特異的結合の低減
US20090247420A1 (en) * 2005-12-12 2009-10-01 Kutateladze Andrei G Method for encoding and screening combinatorial libraries
US7226752B1 (en) * 2006-01-19 2007-06-05 Avago Technologies General Ip (Singapore) Pte. Ltd. Methods for detecting an analyte in a sample
US20080076139A1 (en) 2006-09-21 2008-03-27 Sharat Singh Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cells
US7790401B2 (en) 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
US8735167B2 (en) * 2007-08-20 2014-05-27 Colorado Seminary, Which Owns And Operates The University Of Denver Photoinduced signal amplification through externally sensitized photofragmentation in masked photosensitizers and photoamplified fluorescence turn-off system
ES2369717T3 (es) * 2007-11-30 2011-12-05 F. Hoffmann-La Roche Ag Estabilización de conjugados que comprenden una molécula conectora de tiourea.
US7910378B2 (en) 2007-12-14 2011-03-22 Siemens Healthcare Diagnostics Inc. Methods for detection of hydrophobic drugs
DK2250498T3 (da) 2008-02-25 2013-02-04 Nestec Sa Lægemiddelvalg til brystcancerterapi under anvendelse af antistof-baserede arrays
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
DE102008049601A1 (de) 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
ES2627909T3 (es) 2009-07-15 2017-08-01 Diatech Holdings, Inc. Selección de fármacos para el tratamiento del cáncer gástrico usando matrices basadas en anticuercuerpos
US8697435B2 (en) * 2009-08-31 2014-04-15 Mbio Diagnostics, Inc. Integrated sample preparation and analyte detection
NZ599460A (en) 2009-10-20 2014-07-25 Nestec Sa Proximity-mediated assays for detecting oncogenic fusion proteins
CN102822676B (zh) 2010-01-12 2015-02-18 雀巢产品技术援助有限公司 用于预测三阴性乳腺癌对疗法的应答的方法
EP2395354A1 (de) 2010-06-10 2011-12-14 Siemens Healthcare Diagnostics Products GmbH Homogener Aktivitätstest zur Bestimmung von enzymatischen Reaktionen
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
US8329424B2 (en) 2010-06-25 2012-12-11 Siemens Healthcare Diagnostics Reduction in false results in assay measurements
CN103384828A (zh) 2010-12-23 2013-11-06 雀巢产品技术援助有限公司 使用基于抗体的阵列进行恶性癌症疗法的药物选择
EP2471945A1 (de) 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Bestimmung von Inhibitoren der Gerinnung
EP2908132B8 (de) 2011-03-02 2019-06-12 Nestec S.A. Vorhersage der Arzneimittelsensitivität von Tumoren der Lunge auf der Basis von molekularen und genetischen Signaturen
SG193626A1 (en) 2011-04-04 2013-10-30 Nestec Sa Methods for predicting and improving the survival of gastric cancer patients
WO2013025532A2 (en) 2011-08-12 2013-02-21 Siemens Healthcare Diagnostics Inc. Detection of sex steroids
ES2553456T3 (es) 2011-09-02 2015-12-09 Nestec S.A. Perfilado de proteínas de ruta de señal para determinar una eficacia terapéutica
WO2013086031A1 (en) 2011-12-05 2013-06-13 Nestec S.A. Method of therapy selection for patients with cancer
CN102735833B (zh) * 2012-07-09 2015-01-21 沃克(天津)生物科技有限公司 甲状腺过氧化物酶抗体均相发光免疫分析试剂盒及其检测方法
CN102798725B (zh) * 2012-08-13 2015-03-18 沃克(天津)生物科技有限公司 血清总IgE测定诊断试剂盒及制备和使用方法
KR101933620B1 (ko) * 2012-09-18 2018-12-28 삼성전자주식회사 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법
WO2015003945A1 (en) 2013-07-09 2015-01-15 Nestec S.A. Microfluidic collaborative enzyme enhanced reactive ceer immunoassay
US9121859B2 (en) 2012-12-04 2015-09-01 Siemens Healthcare Diagnostics Inc. Compounds and methods for determination of FKBP-binding immunosuppressant drugs
WO2014122600A1 (en) 2013-02-05 2014-08-14 Nestec S.A. Methods of selecting combination therapy for colorectal cancer patients
WO2014122599A1 (en) 2013-02-05 2014-08-14 Nestec S.A. Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling
WO2014122582A1 (en) 2013-02-05 2014-08-14 Nestec S.A. Drug selection for non-small cell lung cancer therapy
EP2972346A4 (de) * 2013-03-15 2016-12-07 Siemens Healthcare Diagnostics Inc Heterogene lumineszente sauerstoffkanalisierungs-immunoassays und verfahren zur herstellung und verwendung davon
US10371643B2 (en) * 2013-03-15 2019-08-06 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays
EP2999966B1 (de) 2013-05-21 2018-04-25 Pierian Holdings, Inc. Verfahren zur vorhersage und verbesserung des überlebens von patienten mit kolorektalkarzinom
EP3039429B1 (de) 2013-08-30 2018-10-10 Nestec S.A. Wiederauftreten von polypen
EP3077538A1 (de) 2013-12-03 2016-10-12 Nestec S.A. Signalwege in gewebe von patienten mit entzündlicher darmerkrankung
ES2740851T3 (es) 2013-12-13 2020-02-06 Siemens Healthcare Diagnostics Inc Agente de tratamiento previo en ensayos sin aglutinación
ES2614352T3 (es) 2014-03-11 2017-05-30 Siemens Healthcare Diagnostics Products Gmbh Método para la detección de moduladores de la interacción de GPIb-trombina
EP2955517A1 (de) 2014-06-10 2015-12-16 Siemens Healthcare Diagnostics Products GmbH Verfahren zur Stabilisierung von Körperflüssigkeitsproben durch die Zugabe von Detergenz
MX2018004029A (es) 2015-10-02 2018-07-06 Tgr Biosciences Pty Ltd Deteccion de analitos con multiples sustratos.
CN106093391A (zh) * 2016-05-31 2016-11-09 南方医科大学 一种基于单线态氧通道发光量子点传感器
CA3031084C (en) 2016-07-18 2023-04-18 Siemens Healthcare Diagnostics Inc. Sample analyzer system with a sample vessel having opaque and translucent portions
ES2826394T3 (es) 2017-06-09 2021-05-18 Siemens Healthcare Diagnostics Products Gmbh Ensayo de activación para el diagnóstico de una trombocitopenia inducida por heparina
ES2862434T3 (es) 2017-08-02 2021-10-07 Siemens Healthcare Diagnostics Products Gmbh Prueba de unión para el diagnóstico de trombocitopenia inducida por heparina
AU2018331400A1 (en) 2017-09-13 2020-04-02 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
EP3514541A1 (de) 2018-01-17 2019-07-24 Siemens Healthcare Diagnostics Products GmbH Verfahren zur quantitativen bestimmung eines therapeutischen tnf-alpha inhibitors
WO2019213484A1 (en) 2018-05-04 2019-11-07 Siemens Healthcare Diagnostics Inc. Illumination unit with multiple light sources for generating a uniform illumination spot
US20210214368A1 (en) * 2018-06-01 2021-07-15 University Of Oregon Compounds for thiol-triggered cos and/or h2s release and methods of making and using the same
JP7421504B2 (ja) 2018-06-01 2024-01-24 ビオラ・セラピューティクス・インコーポレイテッド 胃腸のマイクロバイオームの検出および操作のためのデバイスおよびシステム
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor
CN112679518B (zh) * 2020-12-29 2022-11-08 华东理工大学 基于硫代色满酮衍生物的纯有机室温磷光材料及其制备方法和应用
EP4239338A1 (de) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Globaltest zur feststellung des status des blutgerinnungssystems
EP4325224A1 (de) 2022-08-18 2024-02-21 Siemens Healthcare Diagnostics Products GmbH Thrombozytenaktivierungstest zur diagnose einer heparin-induzierten thrombozytopenie

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013528A (en) * 1974-03-26 1977-03-22 Xerox Corporation Process for preparation of solid phase dispersion of photoconductive materials
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US4650770A (en) * 1981-04-27 1987-03-17 Syntex (U.S.A.) Inc. Energy absorbing particle quenching in light emitting competitive protein binding assays
CA1190838A (en) * 1981-07-17 1985-07-23 Cavit Akin Homogeneous nucleic acid hybridization diagnostics by non-radiative energy transfer
CA1180647A (en) * 1981-07-17 1985-01-08 Cavit Akin Light-emitting polynucleotide hybridization diagnostic method
CA1294285C (en) * 1983-03-13 1992-01-14 Robert T. Buckler Optical indicator chalcogen compounds and methods for their preparation and use
US4599303A (en) * 1983-12-12 1986-07-08 Hri Associates, Inc. Nucleic acid hybridization assay employing probes crosslinkable to target sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4822733A (en) * 1985-05-28 1989-04-18 Amoco Corporation Lifetime-resolved assay procedures
US4908307A (en) * 1986-12-19 1990-03-13 Karin D. Rodland Hybridization method and probe for detecting nucleic acid sequences
US4891324A (en) * 1987-01-07 1990-01-02 Syntex (U.S.A.) Inc. Particle with luminescer for assays
US4806485A (en) * 1987-02-27 1989-02-21 Cooperative Institute For Research In Environmental Sciences Univers. Of Colorado Method of improving the detection limits of UV-VIS absorbing compounds in HPLC by the use of a singlet oxygen trap
WO1989012232A1 (en) * 1988-06-08 1989-12-14 London Diagnostics, Inc. Assays utilizing sensitizer-induced production of detectable signals
US5019496A (en) * 1989-02-17 1991-05-28 Gerald Oster Photopolymerization diagnostic test composition and method for immunoassay and nucleic acid assay
CA2035029C (en) * 1989-09-06 2001-12-18 Brooks Edwards Synthesis of stable water-soluble chemiluminescent 1,2-dioxetanes and intermediates therefor
EP0476556A3 (en) * 1990-09-18 1992-11-19 Takeda Chemical Industries, Ltd. Method for determination of a light sensitive substance
EP1418430A3 (de) * 1991-05-22 2004-09-01 Dade Behring Marburg GmbH Homogenes Testverfahren zur Bestimmung eines Analyten
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
ATE162892T1 (de) * 1992-07-31 1998-02-15 Behringwerke Ag Photoaktivierbare chemiluminizierende matrices

Also Published As

Publication number Publication date
ATE177842T1 (de) 1999-04-15
JPH09502520A (ja) 1997-03-11
US5616719A (en) 1997-04-01
ES2135597T3 (es) 1999-11-01
WO1995006877A1 (en) 1995-03-09
DE69417242T2 (de) 1999-07-08
EP0716746A1 (de) 1996-06-19
EP0716746B1 (de) 1999-03-17
US5807675A (en) 1998-09-15
CA2170873A1 (en) 1995-03-09
JP3498960B2 (ja) 2004-02-23

Similar Documents

Publication Publication Date Title
DE69417242T2 (de) Fluoreszenz-sauerstoffkanalisation-immunteste
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
ATE195737T1 (de) Antagonisten des fibrinogenrezeptors
ES2081636T3 (es) Preparacion de piperidinas sustituidas.
DE69509875D1 (de) Nipecotinsäurederivate als antithrombische verbindungen
SE8500107D0 (sv) Neue 8alfa-acylaminoergoline
ES8707508A1 (es) Procedimiento para preparar derivados del estilbeno asimetricos conteniendo triazinilo
AU588065B2 (en) Substituted diazaoxaspirodecanes, preparation thereof and use thereof as stabilizers for polymers
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
DE68911237D1 (de) Nichtionische Trijodbenzin-Verbindungen und diese enthaltende Kontrastmittel.
DE69524064D1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
ES2079724T3 (es) Nuevos compuestos antibioticos y su produccion.
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
ECSP961927A (es) Mezclas sinergeticas que contienen ciclohexenonoxim eteres

Legal Events

Date Code Title Description
8364 No opposition during term of opposition